COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 177 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2023. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $56,545,713 | -10.4% | 2,631,257 | +0.0% | 0.96% | -17.4% |
| Q1 2023 | $63,096,987 | +3.4% | 2,630,137 | +0.0% | 1.16% | -3.7% |
| Q4 2022 | $61,006,558 | +44.8% | 2,629,593 | 0.0% | 1.20% | +45.1% |
| Q3 2022 | $42,126,000 | -9.6% | 2,629,593 | 0.0% | 0.83% | -16.9% |
| Q2 2022 | $46,596,000 | -13.0% | 2,629,593 | 0.0% | 1.00% | +18.8% |
| Q1 2022 | $53,539,000 | +9.0% | 2,629,593 | 0.0% | 0.84% | +33.6% |
| Q4 2021 | $49,121,000 | -5.4% | 2,629,593 | 0.0% | 0.63% | -8.2% |
| Q3 2021 | $51,908,000 | -16.5% | 2,629,593 | 0.0% | 0.68% | -18.1% |
| Q2 2021 | $62,164,000 | +8.0% | 2,629,593 | +8.3% | 0.84% | -2.1% |
| Q1 2021 | $57,543,000 | +18.3% | 2,427,976 | 0.0% | 0.85% | +14.3% |
| Q4 2020 | $48,632,000 | -3.8% | 2,427,976 | 0.0% | 0.75% | -24.6% |
| Q3 2020 | $50,550,000 | +19.0% | 2,427,976 | 0.0% | 0.99% | +7.1% |
| Q2 2020 | $42,490,000 | +7.2% | 2,427,976 | 0.0% | 0.92% | -28.0% |
| Q1 2020 | $39,649,000 | -20.7% | 2,427,976 | 0.0% | 1.28% | -8.8% |
| Q4 2019 | $49,968,000 | +79.3% | 2,427,976 | 0.0% | 1.41% | +52.9% |
| Q3 2019 | $27,873,000 | -12.7% | 2,427,976 | 0.0% | 0.92% | -5.1% |
| Q2 2019 | $31,928,000 | -4.5% | 2,427,976 | +10.0% | 0.97% | -15.6% |
| Q1 2019 | $33,423,000 | -11.8% | 2,207,610 | 0.0% | 1.15% | -31.5% |
| Q4 2018 | $37,905,000 | +16.5% | 2,207,610 | 0.0% | 1.68% | +40.4% |
| Q3 2018 | $32,540,000 | -38.2% | 2,207,610 | 0.0% | 1.20% | -45.3% |
| Q2 2018 | $52,651,000 | -6.7% | 2,207,610 | 0.0% | 2.18% | -17.3% |
| Q1 2018 | $56,404,000 | +38.4% | 2,207,610 | 0.0% | 2.64% | +24.3% |
| Q4 2017 | $40,752,000 | +76.0% | 2,207,610 | 0.0% | 2.12% | +61.9% |
| Q3 2017 | $23,158,000 | -16.1% | 2,207,610 | 0.0% | 1.31% | -23.7% |
| Q2 2017 | $27,617,000 | +27.5% | 2,207,610 | +2.5% | 1.72% | +19.9% |
| Q1 2017 | $21,665,000 | -33.0% | 2,153,612 | +3.7% | 1.43% | -31.9% |
| Q4 2016 | $32,351,000 | -16.4% | 2,077,751 | +3.4% | 2.10% | -11.0% |
| Q3 2016 | $38,718,000 | +67.5% | 2,010,278 | +3.1% | 2.36% | +67.2% |
| Q2 2016 | $23,111,000 | -31.7% | 1,950,276 | +4.6% | 1.41% | -25.3% |
| Q1 2016 | $33,855,000 | +15.4% | 1,865,278 | +74.9% | 1.89% | +29.1% |
| Q4 2015 | $29,326,000 | +36.0% | 1,066,400 | +9.3% | 1.47% | +17.0% |
| Q3 2015 | $21,566,000 | +62.1% | 975,418 | +30.8% | 1.25% | +74.0% |
| Q2 2015 | $13,305,000 | – | 745,802 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 304,689 | $6,547,767 | 3.22% |
| Rubric Capital Management LP | 3,425,000 | $73,603,250 | 3.15% |
| Tamarack Advisers, LP | 375,000 | $8,058,750 | 2.49% |
| Mesirow Institutional Investment Management, Inc. | 436,189 | $9,373,702 | 0.97% |
| Eventide Asset Management | 2,631,257 | $56,545,713 | 0.96% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 677,160 | $14,552,168 | 0.79% |
| EMERALD ADVISERS, LLC | 804,790 | $17,294,937 | 0.76% |
| Camber Capital Management LP | 1,050,000 | $22,565 | 0.74% |
| AlphaCentric Advisors LLC | 49,500 | $1,063,755 | 0.59% |
| Values First Advisors, Inc. | 36,950 | $794,055 | 0.48% |